Software company DocuSign’s (DOCU) stock scored a rating upgrade from Hold to Buy from William Blair, thanks to the optimism ...
Research analysts at William Blair issued their Q1 2026 earnings estimates for shares of argenx in a research note issued on ...
Equities researchers at William Blair issued their Q4 2026 earnings estimates for argenx in a report released on Monday, ...
2d
Fintel on MSNWilliam Blair Upgrades DocuSign (DOCU)Fintel reports that on March 17, 2025, William Blair upgraded their outlook for DocuSign (NasdaqGS:DOCU) from Market Perform ...
2d
Fintel on MSNWilliam Blair Initiates Coverage of Butterfly Network (BFLY) with Outperform RecommendationFintel reports that on March 17, 2025, William Blair initiated coverage of Butterfly Network (NYSE:BFLY) with a Outperform ...
We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a ...
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
We recently published a list of 11 Best Reddit Stocks to Invest In. In this article, we are going to take a look at where ...
Overall, Palantir has had a solid start to 2025. Its growth numbers look impressive, and its AI platform is gaining traction across industries. Yet not everyone is convinced. Some ...
The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...
In a report released today, Ross Sparenblek from William Blair maintained a Buy rating on MSA Safety (MSA – Research Report). The company’s shares opened today at $149.45. Easily identify ...
William Blair Emerg Mkts ex China Growth earns a Below Average Process Pillar rating. The process is strengthened by low costs across its parent firm's funds, whose fees rank in their respective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results